Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

QR Code

Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America

Abstract The prevalence and contribution of BRCA1/2 (BRCA) pathogenic variants (PVs) to the cancer burden in Latin America are not well understood. This study aims to address this disparity. BRCA analyses were performed on prospectively enrolled Latin American Clinical Cancer Genomics Community Rese...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Josef S. Herzog, Yanin Chavarri-Guerra, Danielle Castillo, Julio Abugattas, Cynthia Villarreal-Garza, Sharon Sand, Jessica Clague-Dehart, Rosa M. Alvarez-Gómez, Talia Wegman-Ostrosky, Alejandro Mohar, Pamela Mora, Azucena Del Toro-Valero, Adrian Daneri-Navarro, Yenni Rodriguez, Marcia Cruz-Correa, Patricia Ashton-Prolla, Bárbara Alemar, Rosa Mejia, Lenny Gallardo, Robin Shaw, Kai Yang, Aleck Cervantes, Kevin Tsang, Bita Nehoray, Hugo Barrera Saldana, Susan Neuhausen, Jeffrey N. Weitzel
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/cf08a7f700d74cf8b958e3c34a9237a2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
par: Kara N. Maxwell, et autres
Publié: (2017)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
par: Ilirjana Bajrami, et autres
Publié: (2021)

Telomere length shows no association with BRCA1 and BRCA2 mutation status.
par: Emma Killick, et autres
Publié: (2014)

BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
par: Lara,Karlena, et autres
Publié: (2012)

In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
par: Kok-Siong Poon
Publié: (2021)

Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
par: D. Torres, et autres
Publié: (2017)

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
par: Nicolai Juul Birkbak, et autres
Publié: (2013)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
par: Dominik Glodzik, et autres
Publié: (2020)

Clinical consequences of BRCA2 hypomorphism
par: Laia Castells-Roca, et autres
Publié: (2021)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
par: Miyuki Kitahara, et autres
Publié: (2021)

Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations
par: Neil M. Iyengar, et autres
Publié: (2021)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
par: Hikmat Abdel-Razeq, et autres
Publié: (2021)

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
par: Yanying Huo, et autres
Publié: (2021)

Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.
par: Felipe Vaca-Paniagua, et autres
Publié: (2012)

Next-generation sequencing of BRCA1 and BRCA2 genes in Moroccan prostate cancer patients with positive family history.
par: Fatiha Salmi, et autres
Publié: (2021)

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
par: Supriya Behl, et autres
Publié: (2020)

Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
par: Martin J Larsen, et autres
Publié: (2013)

Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations
par: Jara,Lilian, et autres
Publié: (2017)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
par: Juliette Coignard, et autres
Publié: (2021)

Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer.
par: Louise J Barber, et autres
Publié: (2011)

Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
par: Shoko Takeuchi, et autres
Publié: (2018)

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history.
par: Gaik Theng Toh, et autres
Publié: (2008)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
par: Juliette Coignard, et autres
Publié: (2021)

Cáncer de mama familiar, BRCA1 positivo
par: FIGUEROA G,LUIS, et autres
Publié: (2009)

BRCA2 mutations and triple-negative breast cancer.
par: Peter Meyer, et autres
Publié: (2012)

Mutations in BRCA2 and taxane resistance in prostate cancer
par: Cathleen Nientiedt, et autres
Publié: (2017)

Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
par: Ana Blanco, et autres
Publié: (2013)

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
par: Dirce Maria Carraro, et autres
Publié: (2013)

The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells
par: Jingjing Zhang, et autres
Publié: (2020)

Absence of BRCA/FMR1 correlations in women with ovarian cancers.
par: Norbert Gleicher, et autres
Publié: (2014)

Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer.
par: Franziska Pern, et autres
Publié: (2012)

BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?
par: Andrea Weghofer, et autres
Publié: (2012)

Polymorphic repeat length in the AIB1 gene and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis of observational studies.
par: Aida Bianco, et autres
Publié: (2013)

Analysis of 5382insC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of breast cancer
par: JARA,LILIAN, et autres
Publié: (2002)

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
par: Mia M Gaudet, et autres
Publié: (2010)

Pathogenic <i>BRCA</i> Variants as Biomarkers for Risk in Prostate Cancer
par: Ciara S. McNevin, et autres
Publié: (2021)

High-throughput functional evaluation of BRCA2 variants of unknown significance
par: Masachika Ikegami, et autres
Publié: (2020)

Proper chromosome alignment depends on BRCA2 phosphorylation by PLK1
par: Åsa Ehlén, et autres
Publié: (2020)

Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
par: Xia Ding, et autres
Publié: (2016)

BRCA1 degradation in response to mitochondrial damage in breast cancer cells
par: Kana Miyahara, et autres
Publié: (2021)